Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo- controlled trial.
Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC (2019).
Neuropsychiatr Dis Treat. 15:1193-1209.
Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients.
Yonezawa K, Nonaka S, Iwakura Y, et al. (2018).
J Neural Transm (Vienna). 125:1395-1400.
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).
Banaschewski T, Belsham B, Bloch MH, et al. (2018).
Nutr Health. 24:279-84.
Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials.
Vesco AT, Young AS, Arnold LE, Fristad MA (2018).
J Child Psychol Psychiatry. 59:628-636.
A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
Cornu C, Mercier C, Ginhoux T, et al. (2018).
Eur Child Adolesc Psychiatry. 27:377-84.
Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.
Chang JP, Su KP, Mondelli V, Pariante CM (2018).
Current evidence and future directions for research with omega-3 fatty acids and attention deficit hyperactivity disorder.
Gow RV, Hibbeln JR, Parletta N (2015).
Curr Opin Clin Nutr Metab Care. 18:133-8.
Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.
Hawkey E, Nigg JT (2014).
Clin Psychol Rev. 34:496-505.
Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder.
Gow RV, Vallee-Tourangeau F, Crawford MA, et al (2013).
Prostaglandins Leukot Essent Fatty Acids. 88:411-8.
Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.
Bloch MH, Qawasmi A (2011).
J Am Acad Child Adolesc Psychiatry 50:991-1000.